Parameswaran Venugopal, MD, Hematology, Chicago, IL, Rush Oak Park Hospital

ParameswaranVenugopalMD

Hematology Chicago, IL

Hematologic Oncology

Consultants in Hematology

Dr. Venugopal is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Venugopal's full profile

Already have an account?

Education & Training

  • University of LondonOTHER_TRAINING
  • OtherMEDICAL_SCHOOL

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1993 - 2023

Awards, Honors, & Recognition

  • “Honored Hematologist” Award Leukemia Lymphoma Society, 2012
  • “Hero of Hope” Leukemia Research Foundation, 2012
  • Excellence in Medicine Award 2010
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Impact of Insulin-Like Growth Factor-1 & Insulin-Like Growth Factor Binding Protiens On Outcomes in Acute Myeloid Leukemia  
    Karmali, Reem; Larson, Melissa L; Shammo, Jamile; Basu, Sanjib; Christopherson, Kent W; Borgia, Jeffery A; Venugopal, Parameswaran, Leukemia & Lymphoma, 1/1/2015
  • A phase III open label randomized study of cytarabine in comibination with amonafide L-malate or daunorubicin as inducation therapy for patients with secondary acute ...  
    Richard Stone, Emmanuele Mazola, Steven L Allen, Arnaud Pigneux, Robert K. Stuart, Meir Wetzler, David Rizzieri, Harry Paul Erba, Lloyd Damon, Junho Jang, Martin S. Ta..., Journal of Clinical Oncology, 1/1/2015
  • All in The Family: Clueing Into The Link Between Metabolic Syndrome and Hematologic Malignancies  
    Reem Karmali, Hari Parameswaran, Hillard Lazarus and Parameswaran Venugopal, Blood Reviews, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
    Parameswaran Venugopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
    Parameswaran Venugopal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Marked lymphocytosis in Hairy Cell Leukemia: Need for caution when diagnosing Variant Hairy Cell Leukemia
    Sahr Syed, Jason Macklis, Parameswaran Venugopal, Brett Mahon, CAP’15 meeting, Nashville, TN, 1/7/2015
  • Join now to see all

Lectures

  • Copanlisib for Follicular Lymphoma. FDA Approvals and Their Incorporation into Clinical Practice 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
  • Management of High Risk Aggressive Lymphoma 
    Coeur d'alene, ID - 1/28/2015
  • Hodgkin Lymphoma, management 
    1/26/2015
  • Join now to see all

Press Mentions

  • Lessons Learned About Dying from a Dying Son, on World Cancer Day 2020
    Lessons Learned About Dying from a Dying Son, on World Cancer Day 2020January 30, 2020
  • Novel Agents Strengthen Treatment Armamentarium in Non-Hodgkin Lymphoma
    Novel Agents Strengthen Treatment Armamentarium in Non-Hodgkin LymphomaJanuary 03, 2020

Professional Memberships

Hospital Affiliations